MDXHealth SA's Form 6-K: Key Updates & SEC Compliance Report (Jan 2025)

Here are the key pieces of information extracted from the provided financial report section:
- Document Type: Form 6-K - Report of Foreign Private Issuer
- Filing Date: January 13, 2025
- Company Name: MDXHealth SA
- SEC Commission File Number: 001-40996
- Address: CAP Business Center, Zone Industrielle des Hauts-Sarts, 4040 Herstal, Belgium
- Contact Information: +32 4 257 70 21
- Report Purpose: This document is a report filed under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
- Annual Report Filing: The company indicates that it will file under Form 20-F and not Form 40-F.
- Exhibit Included: The report includes a press release dated January 13, 2025, which is attached as Exhibit 99.1.
- Legal Disclaimer: Information in Exhibit 99.1 is being furnished and not deemed "filed" under the Securities Exchange Act of 1934.
- Signature: Signed by Michael McGarrity, Chief Executive Officer, on January 13, 2025.
Insights:
- MDXHealth SA is actively maintaining its compliance with SEC regulations by filing the appropriate forms.
- The company is headquartered in Belgium, indicating its status as a foreign private issuer.
- The inclusion of a press release suggests the company may have important updates or announcements that could impact its operations or stock value.
- The choice of Form 20-F suggests the company is aligning with international reporting standards, which may be beneficial for attracting global investors.